Poop pills for heart health? new study tests gut bacteria transplant in diabetes patients
NCT ID NCT07421947
First seen Feb 19, 2026 · Last updated Jun 19, 2026 · Updated 18 times
Summary
This pilot study tests whether transferring gut bacteria from a healthy donor (fecal microbiota transplant) can change the gut microbiome of 30 people with type 2 diabetes and stable coronary artery disease. Participants receive the transplant via colonoscopy and are monitored for 6 months to see if their gut bacteria, blood sugar, cholesterol, and inflammation improve. The goal is to gather safety and feasibility data, not to prove a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.